These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26246562)

  • 1. Global Database-Driven Assessment of HIV-1 Adaptation to the Immune Repertoires of Human Populations.
    Karakas A; Brumme ZL; Poon AF
    J Virol; 2015 Oct; 89(20):10693-5. PubMed ID: 26246562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
    Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.
    Leslie A; Kavanagh D; Honeyborne I; Pfafferott K; Edwards C; Pillay T; Hilton L; Thobakgale C; Ramduth D; Draenert R; Le Gall S; Luzzi G; Edwards A; Brander C; Sewell AK; Moore S; Mullins J; Moore C; Mallal S; Bhardwaj N; Yusim K; Phillips R; Klenerman P; Korber B; Kiepiela P; Walker B; Goulder P
    J Exp Med; 2005 Mar; 201(6):891-902. PubMed ID: 15781581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1.
    Carlson JM; Listgarten J; Pfeifer N; Tan V; Kadie C; Walker BD; Ndung'u T; Shapiro R; Frater J; Brumme ZL; Goulder PJ; Heckerman D
    J Virol; 2012 May; 86(9):5230-43. PubMed ID: 22379086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
    Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
    Bhattacharya T; Daniels M; Heckerman D; Foley B; Frahm N; Kadie C; Carlson J; Yusim K; McMahon B; Gaschen B; Mallal S; Mullins JI; Nickle DC; Herbeck J; Rousseau C; Learn GH; Miura T; Brander C; Walker B; Korber B
    Science; 2007 Mar; 315(5818):1583-6. PubMed ID: 17363674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome.
    Boutwell CL; Essex M
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):165-74. PubMed ID: 17263647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.
    Sipsas NV; Kalams SA; Trocha A; He S; Blattner WA; Walker BD; Johnson RP
    J Clin Invest; 1997 Feb; 99(4):752-62. PubMed ID: 9045880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
    Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
    J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
    Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
    J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
    Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.
    Gatanaga H; Murakoshi H; Hachiya A; Hayashida T; Chikata T; Ode H; Tsuchiya K; Sugiura W; Takiguchi M; Oka S
    Clin Infect Dis; 2013 Oct; 57(7):1051-5. PubMed ID: 23797286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV evolution: CTL escape mutation and reversion after transmission.
    Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
    Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.